Autologous stem cell transplantation in Hodgkin's disease

被引：3

作者：

Avivi, I ^{[1
]}

Goldstone, AH ^{[1
]}

机构：

[1] UCL Hosp, London, England

来源：

ANNALS OF ONCOLOGY | 2002年 / 13卷

关键词：

D O I：

10.1093/annonc/13.S1.122

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：122 / 127

页数：6

共 42 条

[1] André M, 1998, BLOOD, V92, P1933
[2] Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure:: A case-control study
André, M
Henry-Amar, M
Pico, JL
Brice, P
Blaise, D
Kuentz, M
Coiffier, B
Colombat, P
Cahn, JY
Attal, M
Fleury, J
Milpied, N
Nedellec, G
Biron, P
Tilly, H
Jouet, JP
Gisselbrecht, C
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 222 - 229
[3] Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents
Baker, KS
Gordon, BG
Gross, TG
Abromowitch, MA
Lyden, ER
Lynch, JC
Vose, JM
Armitage, JO
Coccia, PF
Bierman, PJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 825 - 831
[4] BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT
BARTLETT, NL
ROSENBERG, SA
HOPPE, RT
HANCOCK, SL
HORNING, SJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) : 1080 - 1088
[5] YTTRIUM-90-LABELED ANTIFERRITIN FOLLOWED BY HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS HODGKINS-DISEASE
BIERMAN, PJ
VOSE, JM
LEICHNER, PK
QUADRI, SM
ARMITAGE, JO
KLEIN, JL
ABRAMS, RA
DICKE, KA
VRIESENDORP, HM
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) : 698 - 703
[6] Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD
Bonfante, V
Santoro, A
Viviani, S
Devizzi, L
Balzarotti, M
Soncini, F
Zanini, M
Valagussa, P
Bonadonna, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 528 - 534
[7] Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy
Carella, AM
Prencipe, E
Pungolino, E
Lerma, E
Frassoni, F
Rossi, E
Giordano, D
Occhini, D
Gatti, AM
Bruni, R
Spriano, M
Nati, S
Pierluigi, D
Congiu, M
Vimercati, R
Ravetti, JL
Federico, M
[J]. LEUKEMIA & LYMPHOMA, 1996, 21 (1-2) : 63 - 70
[8] CHOPRA R, 1993, BLOOD, V81, P1137
[9] HIGH-DOSE ETOPOSIDE AND MELPHALAN, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ADVANCED HODGKINS-DISEASE - IMPORTANCE OF DISEASE STATUS AT TRANSPLANT
CRUMP, M
SMITH, AM
BRANDWEIN, J
COUTURE, F
SHERRET, H
SUTTON, DMC
SCOTT, JG
MCCRAE, J
MURRAY, C
PANTALONY, D
SUTCLIFFE, SB
KEATING, A
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) : 704 - 711
[10] INCIDENCE AND CHARACTERIZATION OF SECONDARY MYELODYSPLASTIC SYNDROME AND ACUTE MYELOGENOUS LEUKEMIA FOLLOWING HIGH-DOSE CHEMORADIOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR LYMPHOID MALIGNANCIES
DARRINGTON, DL
VOSE, JM
ANDERSON, JR
BIERMAN, PJ
BISHOP, MR
CHAN, WC
MORRIS, ME
REED, EC
SANGER, WG
TARANTOLO, SR
WEISENBURGER, DD
KESSINGER, A
ARMITAGE, JO
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) : 2527 - 2534

← 1 2 3 4 5 →